What Are Liver Enzymes and What Do They Signal?
The term "liver enzymes" is used loosely to refer to a group of proteins — primarily ALT, AST, ALP, and GGT — that are measured in a routine blood panel. Technically, only ALT and AST are truly enzyme markers of hepatocyte (liver cell) injury. ALP and GGT are better described as markers of biliary and cholestatic disease. All four are important, and it is their pattern in combination that tells the most useful clinical story.
These enzymes leak into the bloodstream when liver cells are damaged or when bile flow is impaired. Elevated levels are a signal — not a diagnosis — and require interpretation alongside symptoms, other blood tests, imaging, and clinical history. A single mildly elevated value often means little. A pattern of multiple elevated values, or a trend that is rising over time, is far more meaningful.
| Enzyme | Also Called | Primary Source | What It Signals |
|---|---|---|---|
| ALT | SGPT, Alanine Aminotransferase | Hepatocytes (liver cells) | Hepatocyte injury — the most liver-specific enzyme |
| AST | SGOT, Aspartate Aminotransferase | Liver, heart, muscle, kidney | Hepatocyte injury (less specific — multiple organ sources) |
| ALP | Alkaline Phosphatase | Bile duct lining, bone, intestine, placenta | Biliary/cholestatic disease or bone turnover |
| GGT | Gamma-GT, γ-GT | Liver, bile ducts, kidney | Cholestatic disease, alcohol use, drug induction, fatty liver |
ALT (Alanine Aminotransferase / SGPT)
ALT is the cornerstone liver injury marker. It is found predominantly in hepatocytes and is released into the blood when they are damaged or destroyed. Because it is so liver-specific, an elevated ALT almost always points to the liver as the source — unlike AST, which can rise from heart, muscle, or kidney damage.
ALT Normal Ranges: The Old Cutoffs vs. the New
Most laboratory reports flag ALT above 40–56 U/L as elevated — a threshold set decades ago based on population means. Current AASLD guidelines recommend lower, sex-specific thresholds that better identify early liver disease:
| Reference | Men | Women | Note |
|---|---|---|---|
| Traditional lab ULN | 40–56 U/L | 40–56 U/L | Still used by most laboratory reports |
| AASLD recommended ULN | 30 U/L | 19 U/L | Better sensitivity for early MASLD |
| Persistently elevated (concern) | > 30 U/L | > 19 U/L | Warrants investigation if sustained > 3–6 months |
| Significant elevation | > 3× ULN | > 3× ULN | Prompt hepatology evaluation indicated |
Many patients with significant liver disease — including early MASLD and even compensated cirrhosis — have ALT values within their laboratory's "normal" range. This is why the AASLD lowered its recommended thresholds: the old cutoffs missed too many early diagnoses in women especially, where the traditional 40 U/L ULN was set almost entirely on male reference populations.
AST (Aspartate Aminotransferase / SGOT)
AST is elevated in liver cell injury but is also found in significant quantities in cardiac muscle, skeletal muscle, and the kidneys. This multi-organ origin makes it less specific for liver disease than ALT. The key insight: the AST/ALT ratio (De Ritis ratio) can be more informative than either value alone.
The De Ritis Ratio (AST/ALT): What the Pattern Reveals
| AST/ALT Ratio | Pattern | Most Likely Condition |
|---|---|---|
| < 1 (ALT higher) | Hepatocellular, ALT-dominant | MASLD, viral hepatitis, drug-induced hepatitis, early liver disease |
| 1–2 | Mixed or non-specific | Indeterminate — overlap between causes; depends on absolute levels |
| > 2 (AST dominant) | AST-dominant, mitochondrial | Alcoholic liver disease (ALD); also seen in advanced cirrhosis of any cause |
| > 1 in known non-alcoholic disease | Reversed ratio in cirrhosis | Advanced fibrosis/cirrhosis — ALT production falls as hepatocyte mass depletes |
The De Ritis ratio above 2 is a clinically important sign in the right context. In alcoholic hepatitis, AST rises disproportionately because alcohol depletes pyridoxal phosphate (vitamin B6), which is needed more for ALT synthesis than AST synthesis. Alcohol also preferentially damages mitochondria, releasing mitochondrial AST. The combination produces the classic AST > 2× ALT pattern — though an AST/ALT above 8–10 should raise suspicion for other causes such as ischaemic hepatitis or autoimmune hepatitis.
GGT (Gamma-Glutamyl Transferase)
GGT is the most sensitive liver enzyme for detecting hepatic disease — it is rarely normal when significant liver disease is present. However, its very sensitivity is also its weakness: GGT rises easily from many non-pathological causes, making it the least specific of the four enzymes when used alone.
What Elevates GGT
- Alcohol: The most common cause of isolated GGT elevation. Even moderate regular alcohol intake raises GGT, making it a sensitive but non-specific marker of alcohol use. GGT typically normalises within 2–6 weeks of alcohol abstinence.
- Fatty liver (MASLD): GGT is commonly elevated in metabolic fatty liver disease, often alongside mildly elevated ALT.
- Medications: Many drugs induce GGT production, including anticonvulsants (phenytoin, carbamazepine), rifampicin, statins, antifungals, and hormonal contraceptives — without indicating liver damage.
- Biliary and cholestatic disease: GGT and ALP rise together when bile flow is impaired. This ALP + GGT pattern points to the hepatic or biliary origin of the ALP (bone disease does not raise GGT).
- Thyroid disease and metabolic syndrome: GGT may be mildly elevated in poorly controlled hypothyroidism and insulin resistance.
The ALP + GGT pairing: If ALP is elevated, checking GGT is the fastest way to determine whether the ALP comes from the liver or from bone. GGT is absent from bone — so elevated GGT + elevated ALP = hepatic/biliary source. Normal GGT + elevated ALP = likely bone, pregnancy, or physiological cause. See the full ALP guide for details.
Clinical Enzyme Patterns: Reading the Full Picture
The most clinically useful information comes from the pattern across all four enzymes rather than from any single value. Two fundamental patterns — hepatocellular and cholestatic — point in very different diagnostic directions:
| Pattern | Enzyme Findings | Primary Conditions |
|---|---|---|
| Hepatocellular | ALT & AST markedly elevated (> 3–5× ULN) ALP normal or mildly elevated |
Viral hepatitis (A, B, C, E), autoimmune hepatitis, drug-induced hepatitis, ischaemic hepatitis, MASLD/MASH |
| Cholestatic | ALP & GGT markedly elevated ALT/AST normal or mildly elevated |
Primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), bile duct obstruction, intrahepatic cholestasis of pregnancy |
| Mixed | Both hepatocellular and cholestatic enzymes elevated | Drug-induced liver injury (DILI) — many agents; some viral hepatitis patterns; cholestatic NASH |
| Isolated ALT (mild) | ALT mildly elevated (< 3× ULN), others normal | MASLD (most common); early hepatitis; thyroid disease; coeliac disease; strenuous exercise |
| Isolated GGT | GGT elevated, ALP and ALT/AST normal | Alcohol use; drug induction; metabolic syndrome without significant liver disease |
| Massively elevated ALT/AST (> 10× ULN) | Very high ALT and/or AST | Acute viral hepatitis; ischaemic hepatitis (shock liver); acute drug toxicity (paracetamol/acetaminophen overdose); autoimmune hepatitis |
Liver Enzymes in MASLD: What to Expect and What to Watch
MASLD (fatty liver disease) is the most common reason for mildly elevated liver enzymes in routine blood tests. The characteristic pattern is a modest ALT elevation — often 1.5–3× ULN — with a normal or near-normal AST and a De Ritis ratio below 1. GGT may also be mildly elevated, particularly with metabolic syndrome, central obesity, or alcohol use.
Critically, enzyme levels in MASLD do not reliably predict fibrosis severity. Many patients with advanced fibrosis (F3–F4) have entirely normal or minimally elevated ALT, while some with simple steatosis have disproportionate enzyme elevation. This is why blood-based fibrosis scores like FIB-4 (which uses age, AST, ALT, and platelet count) and imaging-based tests like FibroScan are needed alongside enzyme results to assess disease stage accurately.
A falling ALT in known MASLD is not automatically reassuring — it can reflect hepatocyte burnout in advanced cirrhosis, where the reduced hepatocyte mass produces less ALT even as the liver deteriorates. Rising AST with falling ALT — resulting in a De Ritis ratio shifting above 1 — is a warning sign of advanced fibrosis or cirrhosis even in ostensibly non-alcoholic disease.